Literature DB >> 7016406

Protein degradation in human skeletal muscle tissue: the effect of insulin, leucine, amino acids and ions.

K Lundholm, S Edström, L Ekman, I Karlberg, P Walker, T Scherstén.   

Abstract

1. The protein degradation rate of human skeletal muscle was evaluated in vitro in isolated fibre bundles from the rectus abdominus muscle by measuring the tyrosine released from muscle tissue proteins. Protein metabolism in this semi-intact preparation was compared with that of the intact extensor digitorum longus muscles from rats under the same experimental conditions. 2. Protein balance was negative in both preparations, but protein synthesis and degradation were two to three times higher in the rat muscles. Tyrosine was released at a constant rate for at least 3 h of incubation independent of whether protein synthesis was inhibited or not. Disintegration of the muscle fibres more than doubled the tyrosine release rate. Human red gastrocnemius muscle showed 37% higher degradation rate compared with the predominantly white rectus abdominus muscle. The half-life of human skeletal muscle protein in vitro was estimated to be 20 days when calculated from the rate of tyrosine release. 3. The addition of leucine to the incubation medium decreased the rate of protein degradation, which was further decreased by the addition of other amino acids. Insulin did not influence the protein degradation rate during 2 h of incubation. This did not reflect a lack of sensitivity to insulin of the preparation, since protein synthesis responded to insulin. Calcium (5 mmol/l) stimulated and zinc (0.1 mmol/l) inhibited the protein degradation. 4. This experimental system may be suitable as an additional tool for evaluating protein degradation in human skeletal muscles.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7016406     DOI: 10.1042/cs0600319

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  11 in total

1.  Transport kinetics of amino acids across the resting human leg.

Authors:  K Lundholm; K Bennegård; H Zachrisson; F Lundgren; E Edén; A C Möller-Loswick
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

2.  Acute response of human muscle protein to catabolic hormones.

Authors:  D C Gore; F Jahoor; R R Wolfe; D N Herndon
Journal:  Ann Surg       Date:  1993-11       Impact factor: 12.969

3.  Effect of insulin on system A amino acid transport in human skeletal muscle.

Authors:  R C Bonadonna; M P Saccomani; C Cobelli; R A DeFronzo
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

4.  Specificity of the effects of leucine and its metabolites on protein degradation in skeletal muscle.

Authors:  W E Mitch; A S Clark
Journal:  Biochem J       Date:  1984-09-15       Impact factor: 3.857

5.  Effect of physiologic hyperinsulinemia on skeletal muscle protein synthesis and breakdown in man.

Authors:  R A Gelfand; E J Barrett
Journal:  J Clin Invest       Date:  1987-07       Impact factor: 14.808

Review 6.  Mobilisation of structural proteins during exercise.

Authors:  A Viru
Journal:  Sports Med       Date:  1987 Mar-Apr       Impact factor: 11.136

7.  Plasma amino acid levels in the first few days after burn injury and their predictive value.

Authors:  L Cynober; F Nguyen Dinh; R Saizy; F Blonde; J Giboudeau
Journal:  Intensive Care Med       Date:  1983       Impact factor: 17.440

8.  Decreased protein catabolism after exercise in subjects with IDDM.

Authors:  J T Devlin; A Scrimgeour; I Brodsky; S Fuller
Journal:  Diabetologia       Date:  1994-04       Impact factor: 10.122

9.  Myosin heavy chain 2A and α-actin expression in human and murine skeletal muscles at feeding; particularly amino acids.

Authors:  Britt-Marie Iresjö; Kent Lundholm
Journal:  J Transl Med       Date:  2012-11-28       Impact factor: 5.531

10.  Effects of leucine supplementation and serum withdrawal on branched-chain amino acid pathway gene and protein expression in mouse adipocytes.

Authors:  Abderrazak Kitsy; Skyla Carney; Juan C Vivar; Megan S Knight; Mildred A Pointer; Judith K Gwathmey; Sujoy Ghosh
Journal:  PLoS One       Date:  2014-07-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.